DnB NOR Asset Management AS »

Soleno Therapeutics shares owned by DnB NOR Asset Management AS

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by DnB NOR Asset Management AS from 13F filings

Historical chart of DnB NOR Asset Management AS investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by DnB NOR Asset Management AS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by DnB NOR Asset Management AS

Quarter filed Position value Share count Share price at filing
2025-12-31 $652k 14k 46.30
2025-09-30 $430k 6.4k 67.60
2025-06-30 $223k 2.7k 83.78

More positions owned by DnB NOR Asset Management AS

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Mastercard Cl A (MA)
Visa Com Cl A (V)
Atlassian Corp Cl A (TEAM)
Broadcom (AVGO)
salesforce (CRM)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Check Point Software Tech LT Ord (CHKP)
Alphabet Cap Stk Cl C (GOOG)

View all positions for DnB NOR Asset Management AS

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Wellington Management Company
Nantahala Capital Management
Adage Capital Partners GP
Millennium Management
Commodore Capital
Braidwell
Geode Capital Management
Polar Capital Holdings
Woodline Partners

View all funds holding Soleno Therapeutics